← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2008Last known activity
Apr 30, 2019
Acquired by Johnson and Johnson on Feb 13, 2019
Timeline
2000s
- Apr 1, 2003
Auris Medical— Founded
2010s
- Feb 13, 2019
Johnson and Johnson— Acquired By
2020s
- Jun 3, 2021
Trasir Therapeutics— Acquired
Drugs by trial phase (4 distinct, 10 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (10)
- NCT03908567Lead sponsorPhase 2Apr 30, 2019
- NCT02809118Lead sponsorPhase 3Jun 1, 2016
- NCT02561091Lead sponsorPhase 3Nov 1, 2015
- NCT02040207Lead sponsorPhase 3Jun 1, 2014
- NCT01934010Lead sponsorPhase 3Jun 1, 2014
- NCT01803646Lead sponsorPhase 3Feb 1, 2014
- NCT02040194Lead sponsorPhase 3Jan 1, 2014
- NCT01270282Lead sponsorPhase 2Feb 1, 2011
- NCT00860808Lead sponsorPhase 2Mar 1, 2009
- NCT00802425Lead sponsorPhase 2Dec 1, 2008
Details
- Founded
- Basel, CH Apr 1, 2003
- Last known activity
- Apr 30, 2019